Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction

Circulation

Volumn 111, Issue 20, 2005, Pages 2596-2604

  Lancel, Steve ^a,c   Joulin, Olivier ^a,c   Favory, Raphael ^a,c   Goossens, Jean Francois ^c   Kluza, Jerome ^b   Chopin, Claude ^a   Formstecher, Pierre ^b   Marchetti, Philippe ^b   Neviere, Remi ^a,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

Author keywords

Apoptosis; Inflammation; Myocardial contraction; Myocytes, cardiac; Shock

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALCIUM; CASPASE 3; CASPASE 8; CASPASE 9; ENDOTOXIN; TROPONIN T;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DESTRUCTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE CELL; MALE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMERE; SEPSIS;

EID: 19644369587     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.490979     Document Type: Article

References (27)

1. Angus DC. Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
3. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock, Ann Intern Med. 1984;100:483-490.
4. Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock. Crit Care Clin. 2000;16:251-287.
5. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE, The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280-287.
6. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W, A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 1985;76:1539-1553.
7. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, Korsmeyer SJ, Karl IE. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A. 1999;96:14541-14546.
8. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E. Aspiotis R, Han Y, Nicholson DW, Karl IE. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol. 2000;1:496-501.
9. McDonald TE, Grinman MN, Carthy CM, Walley KR. Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol. 2000;279:H2053-H2061.
10. Meldrum DR. Tumor necrosis factor in the heart, Am J Physiol. 1998;274:R577-R595.
11. Fauvel H, Marchetti P, Chopin C, Formstecher P, Neviere R. Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis. Am J Physiol 2001;280:H1608-H1614.
12. Fauvel H, Marchetti P, Obert G, Joulin O, Chopin C, Formstecher P, Neviere R. Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. Am J Respir Crit Care Med. 2002;165:449-455.
13. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P, Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med. 2001;163:218-225.
14. Gomez AM, Kerfant BG, Vassort G, Microtubule disruption modulates Ca(2+) signaling in rat cardiac myocytes. Circ Res. 2000;86:30-36.
15. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA. 2002;99:6252-6256.
16. Tavernier B. Li JM, El-Omar MM. Lanone S, Yang ZK, Trayer IP, Mebazaa A, Shah AM. Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats. FASEB J. 2001;15:294-296.
17. Laugwitz KL, Moretti A, Weig HJ, Gillitzer A, Pinkernell K. Ott T, Pragst I, Stadele C, Seyfarth M, Schomig A, Ungerer M. Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther. 2001;12:2051-2063.
18. Ruetten H, Badorff C, Ihling C, Zeiher AM, Dimmeler S. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects, J Am Coll Cardiol. 2001;38:2063-2070.
19. 2+ in cardiac myocytes. Circ Res, 1997;81:1011-1020.
20. Hirota J, Furuichi T, Mikoshlba K. Inositol 1,4,5-trisphosphate receptor type 1 is a substrate for caspase-3 and is cleaved during apoptosis in a caspase-3-dependent manner. J Biol Chem. 1999;274:34433-34437.
21. Schwab BL, Guerini D, Didszun C. Bano D, Ferrando-May E. Fava E, Tarn J, Xu D, Xanthoudakis S, Nicholson DW, Carafoli E, Nicotera P, Cleavage of plasma membrane calcium pumps by caspases; a link between apoptosis and necrosis. Cell Death Differ. 2002;9:818-831.
22. Ekert PG, Silke J, Vaux DL. Caspase inhibitors. Cell Death Differ. 1999;6:1081-1086.
23. Garcia-Calvo M, Peterson EP. Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998;273:32608-32613.
24. Fletcher DS, Agarwal L, Chapman KT, Chin J, Egger LA, Limjuco G, Luell S. MacIntyre DE, Peterson EP, Thornberry NA, et al. A synthetic inhibitor of interleukin-1 beta converting enzyme prevents endotoxin-induced interleukin-1 beta production in vitro and in vivo. J Interferon Cytokine Res. 1995;15:243-248.
25. Rodriguez I. Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med. 1996;184:2067-2072.
26. Condorelli G, Roncarati R, Ross J Jr, Pisani A, Stassi G, Todaro M, Trocha S, Drusco A, Gu Y, Russo MA, Frati G, Jones SP. Lefer DJ, Napoli C, Croce CM. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proc Natl Acad Sci U S A. 2001;98:9977-9982.
27. Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe D, Gillitzer A, Bott-Flugel L, Schomig A, Ungerer M. Laugwitz KL. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci U S A. 2002;99:11860-11865.